Once again, the astonishing advances in ophthalmology during the last 25 years have made it necessary to expand a chapter in the Text-Book of Ophthalmology into a volume in this System. Many of our concepts of the <etiology of uveal disease have been changed during this period, and the treatment of many of them -although unfortunately not all -has been revolutionized. It is true that our ignorance of many things we would wish to know is still profound; but undoubtedly the present epoch in the development of medicine is exciting. Indeed, one of the most provocative and frustrating of the illnesses that affect the eye is uveitis, for the <etiology of most cases remains an enigma and, in the absence of a dramatic response to antibiotic drugs, we are often as impotent in our means of therapeusis as were our predecessors, apart from the somewhat cowardly but frequently very practical resource of blanketing the worst of the effects of inflammation by steroid drugs.
I will not review the anatomy, physiology, cell biology, etc., of the uvea; rather I will try to pose a series of questions from my own research -questions which have some bearing on the topics discussed during the symposium. These questions relate to our primate model of ocular histoplasmosis, which we developed in our effort to understand the human disease 'presumed ocular histoplasmosis syndrome' (POHS). We developed our primate model in order to study these questions. 3 As is often the case, however, our research resulted in more questions than answers.
These questions have relevance to our understanding of other disorders of the uveal tract discussed during this symposium.
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